Global Proteomics Market Reports, Market Size, Market Analysis & Forecast 2017-2023

The proteomics market is growing with a significant pace. The increased investment by government and private firms in research and development are the major driving force of the global proteomics market. Increased demand for the personalized medicine is driving the growth in the global proteomics market. The geriatric population and prevalence of lifestyle diseases is boosting the global market along with technological advancements is enhancing the global proteomics market. However, the increasing aging population is having a huge impact on the growth of global proteomics market. According to WHO, the world aged population by the end of 2050 is expected to reach 2 billion that was 900 million in 2015. Now it is around 125 million people aged 80 years or more. By the end of 2050, it has been expected that there will be almost 125 million people aged 80 years or more in China alone and 434 million people across the globe.

The global proteomics market is expected to grow impressively with a remarkable CAGR of 16.35% during the forecast period. The expensive tools & equipment and weak research & development in emerging markets are hampering the growth of proteomics market in the global market.

The major drivers of the proteomics market includes -

Rising investment by governments & private firms in research & development.
Enhancing demand for personalized medicines.
Constant technological advancements in proteomics.
Increase in the prevalence of diseases.

The demand for personalized medicine is increasing day by day and is acting as a key driver in the development and expansion of the Proteomics market on the global scenario. In 2015 oncology diseases amounted the larger share of 38% for the demand of personalized medicines followed by psychiatry at 17%, infectious diseases 10%, cardiology 7% and neurology 6%. In 2014, 1 out of 5 FDA approvals of personalized medicines were for the targeted therapies. Personalized medicines are very effective, around 62% effectiveness in having depression followed by 60% in asthma, 57% in diabetes, alzheimer is accounted at 30%.

The reduction in funds by the US government, which owes 40% of this market and highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research is hindering the growth in global market. The development in drug discovery and nanotechnology and rising markets in emerging countries are creating huge opportunities for the forecasted period in global proteomics market. The increasing research and development activities by the key players and government to explore the efficiency of the proteomics technology across the globe is creating huge opportunities in the global market.
The proteomics market is segmented on the basis of technology, reagents, services, application and geography. The technology segment is segmented into protein microarray, spectroscopy, x-ray crystallography chromatography, electrophoresis, surface plasmon resonance (spr) systems, protein fractionation systems. The protein microarray is further segmented into biochips, microarray instruments. The biochip is further segmented into protein chips, lab-on-chips (microfluidics). The microarray instrument also sub-divided into integrated system, arrayers, microarray scanners. The spectroscopy segment is divided into mass spectroscopy, NMR spectroscopy, circular dichroism (cd) spectroscopy. The chromatography is further segmented into ion chromatography, supercritical fluid chromatography, HPLC systems, affinity chromatography. Electrophoresis is further segmented into gel electrophoresis, capillary electrophoresis. The reagents segment is segmented into microarray reagent, spectroscopy reagent, x-ray crystallography reagent, chromatography reagents, electrophoresis reagents, immunoassay reagents, protein fractionation reagents. The services are segmented into analytical laboratory services, data analysis & maintenance. The analytical laboratory services are segmented into protein identification, protein separation, protein sequencing. The data analysis & maintenance is segmented into bioinformatics databases, bioinformatics tools. However, the application segment is segmented into drug discovery, clinical diagnosis, others.

Source-OBRC Analysis

The report is widely categorized on the basis of market segments includes Technology, Reagents, Services and End-User. Technology is further sub segmented into:

Protein Microarray
Microarray instruments
Spectroscopy instruments
Chromatography
Electrophoresis

Reagents is Further Sub segmented into:

Chromatography reagents
Electrophoresis reagents
Immunoassay reagents
Microarray reagents
Protein Fractionation reagents
Spectroscopy reagents
X-ray crystallography

Services is further Sub segmented into:

Analytical Laboratories services
Protein identification
Protein separation
Protein sequencing
Bioinformatics databases
Bioinformatics tools

End user is further sub segmented into:

Clinical diagnosis market
Drug discovery market

Geographically, the global proteomics market has been segmented on the basis of four major regions, which include:

North America (U.S. & Canada)
Asia Pacific (China, India, Japan, RoAPAC)
Europe (UK, France, Germany, RoE)
Rest of World

The revenue for the above services are specific to the proteomics market. However, the total revenue of these services in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up provider, payer and the pharmaceutical services segment.

The global proteomics market is driven by the existence of some the prominent player in the market such as Abbott Laboratories, Bausch & Lomb, Fresenius Medical Care AG & Co. KGAA, General Electric Co., Johnson & Johnson Inc. (U.S), Medtronic Inc., Phillips Healthcare, Roche Diagnostics Limited, Siemens AG. The mergers & acquisitions, innovation, product development are the key strategies adopted by key players to sustain into competitive market. In 2015, Philips has completed four acquisitions, among all the largest acquisition were with Volcano Corporation, the United States based company basically deals with image guided therapy apart from this Philips healthcare also acquired Blue Jay Consulting, provider of hospital emergency room consulting services.

The major market players of the global proteomics market are:

ABBOTT LABORATORIES
BAUSCH & LOMB
GENERAL ELECTRIC CO
JOHNSON & JOHNSON
SIEMENS AG

Why to buy the report:

This report will:

Provide in detail the different segments such as by technology, reagents which are affecting the global proteomics market.
Provide you the patent analysis of the proteomics market.
Identify and understand the strength, opportunities, challenges and threat of the Proteomics market.
Provide revenues of major players of the market such as Siemens AG and Roche diagnostics Limited.
Provide you various the regulatory policies which are affecting the global proteomics market.

How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global Proteomics market offers the longest chain of market segmentation covering major market segmentation based on products and end users. The report tracks the major market trends in the global Proteomics market such as the Rising investment by governments & private firms in research & development. Enhancing demand for personalized medicines and Constant technological advancements in proteomics.

Increase in the prevalence of diseases is trending the demand for the proteomics market acros the globe. The chronic diseases which includes cancer and diabetes is impacting the growth for the proteomics market. For each market segments covered in global proteomics report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the proteomics industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data.

Key findings of the proteomics market are as follows:

Increasing demand for personalized medicines is fueling growth in global Proteomics market.
North America is anticipated to generate the largest revenue share in 2016.
Enhancing government support.
Mergers & acquisitions is the key strategy adopted by the various market players of global Proteomics market.
Philips has acquired four organizations which include mainly Blue jay consulting and Volcano corporation.

1. INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

2.1. GLOBAL PROTEOMICS MARKET: EVOLUTION & TRANSITION

2.2. MARKET DEFINITION AND SCOPE

2.3. INDUSTRY STRUCTURE

2.4. REGULATORY FRAMEWORK

2.5. TOTAL MARKET ANALYSIS

2.5.1. TOP 5 FINDINGS

2.5.2. TOP 5 OPPORTUNITY MARKETS

2.5.3. TOP 5 COMPANIES

2.5.4. TOP 3 COMPETITIVE STRATEGIES

2.6. ESTIMATION ANALYSIS

2.7. STRATEGIC ANALYSIS

2.7.1. INVESTMENT VS. ADOPTION MODEL

2.7.2. 360 DEGREE INDUSTRY ANALYSIS

2.7.3. PORTERS 5 FORCE MODEL

2.7.4. SEE-SAW ANALYSIS

2.7.5. PRICING ANALYSIS

2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.8. COMPETITIVE ANALYSIS

2.8.1. KEY STRATEGIES AND ANALYSIS

2.8.2. MARKET SHARE

2.8.3. TOP COMPANY ANALYSIS

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS

2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS

2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1. INCREASED FUNDING BY GOVERNMENT AND PRIVATE FIRMS IN RESEARCH & DEVELOPMENT

3.1.2. RISING DEMAND FOR PERSONALIZED MEDICINE

3.1.3. ENHANCED UNDERSTANDING OF HUMAN GENOME

3.1.4. TECHNOLOGICAL ADVANCEMENTS

3.2. MARKET RESTRAINTS

3.2.1. LOW SUCCESS RATIO OF RESEARCHERS

3.2.2. HIGHLY EXPENSIVE MEDICINES

3.2.3. LIMITATION OF MARKET WITHIN THE DEVELOPING NATIONS

3.3. MARKET OPPORTUNITIES

3.3.1. DEVELOPMENT IN DRUG DISCOVERY AND NANOTECHNOLOGY

3.3.2. MARKET IN EMERGING ECONOMIES

3.4. MARKET CHALLENGES

3.4.1. EXPENSIVE TOOLS & EQUIPMENTS

3.4.2. WEAK RESEARCH AND DEVELOPMENT IN EMERGING MARKET

4. MARKET SEGMENTATION

4.1. GLOBAL PROTEOMICS MARKET BY TECHNOLOGY

4.1.1. MARKET DEFINITION AND SCOPE

4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.1.4. OPPORTUNITY MATRIX

4.1.5. MARKET SEGMENTATION

4.1.5.1. GLOBAL PROTEIN MICROARRAY MARKET

4.1.5.1.1. APPLICATIONS

4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.1.5. KEY CONCLUSIONS

4.1.5.2. GLOBAL BIOCHIPS MARKET

4.1.5.2.1. APPLICATIONS

4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.2.5. KEY CONCLUSIONS

4.1.5.3. GLOBAL LAB-ON-CHIPS MARKET

4.1.5.3.1. APPLICATIONS

4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.3.5. KEY CONCLUSIONS

4.1.5.4. GLOBAL MICROARRAY INSTRUMENTS MARKET

4.1.5.4.1. APPLICATIONS

4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.4.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.4.5. KEY CONCLUSIONS

4.1.5.5. GLOBAL INTEGRATED SYSTEMS MARKET

4.1.5.5.1. APPLICATIONS

4.1.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.5.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.5.5. KEY CONCLUSIONS

4.1.5.6. GLOBAL ARRAYERS MARKET

4.1.5.6.1. APPLICATIONS

4.1.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.6.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.6.5. KEY CONCLUSIONS

4.1.5.7. GLOBAL MICROARRAY SCANNERS MARKET

4.1.5.7.1. APPLICATIONS

4.1.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.7.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.7.5. KEY CONCLUSIONS

4.1.5.8. GLOBAL SPECTROSCOPY MARKET

4.1.5.8.1. APPLICATIONS

4.1.5.8.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.8.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.8.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.8.5. KEY CONCLUSIONS

4.1.5.9. GLOBAL CIRCULAR DICHROISM MARKET

4.1.5.9.1. APPLICATIONS

4.1.5.9.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.9.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.9.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.9.5. KEY CONCLUSIONS

4.1.5.10. GLOBAL MASS SPECTROSCOPY MARKET

4.1.5.10.1. APPLICATIONS

4.1.5.10.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.10.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.10.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.10.5. KEY CONCLUSIONS

4.1.5.11. GLOBAL NMR SPECTROSCOPY MARKET

4.1.5.11.1. APPLICATIONS

4.1.5.11.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.11.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.11.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.11.5. KEY CONCLUSIONS

4.1.5.12. GLOBAL X-RAY CRYSTALLOGRAPHY MARKET

4.1.5.12.1. APPLICATIONS

4.1.5.12.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.12.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.12.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.12.5. KEY CONCLUSIONS

4.1.5.13. GLOBAL CHROMATOGRAPHY MARKET

4.1.5.13.1. APPLICATIONS

4.1.5.13.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.13.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.13.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.13.5. KEY CONCLUSIONS

4.1.5.14. GLOBAL AFFINITY CHROMATOGRAPHY MARKET

4.1.5.14.1. APPLICATIONS

4.1.5.14.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.14.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.14.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.14.5. KEY CONCLUSIONS

4.1.5.15. GLOBAL HPLC SYSTEMS MARKET

4.1.5.15.1. APPLICATIONS

4.1.5.15.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.15.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.15.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.15.5. KEY CONCLUSIONS

4.1.5.16. GLOBAL ION CHROMATOGRAPHY MARKET

4.1.5.16.1. APPLICATIONS

4.1.5.16.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.16.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.16.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.16.5. KEY CONCLUSIONS

4.1.5.17. GLOBAL SUPERCRITIAL FLUID CHROMATOGRAPHY MARKET

4.1.5.17.1. APPLICATIONS

4.1.5.17.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.17.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.17.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.17.5. KEY CONCLUSIONS

4.1.5.18. GLOBAL ELECTROPHORESIS MARKET

4.1.5.18.1. APPLICATIONS

4.1.5.18.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.18.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.18.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.18.5. KEY CONCLUSIONS

4.1.5.19. GLOBAL CAPILLARY ELECTROPHORESIS MARKET

4.1.5.19.1. APPLICATIONS

4.1.5.19.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.19.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.19.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.19.5. KEY CONCLUSIONS

4.1.5.20. GLOBAL GEL ELECTROPHORESIS MARKET

4.1.5.20.1. APPLICATIONS

4.1.5.20.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.20.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.20.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.20.5. KEY CONCLUSIONS

4.1.5.21. GLOBAL SURFACE PLASMON RESONANCE MARKET

4.1.5.21.1. APPLICATIONS

4.1.5.21.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.21.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.21.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.21.5. KEY CONCLUSIONS

4.1.5.22. GLOBAL PROTEIN FRACTIONATION SYSTEMS MARKET

4.1.5.22.1. APPLICATIONS

4.1.5.22.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.1.5.22.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.1.5.22.4. TOP PLAYERS & KEY PRODUCTS

4.1.5.22.5. KEY CONCLUSIONS

4.2. GLOBAL PROTEOMICS MARKET BY REAGENTS

4.2.1. MARKET DEFINITION AND SCOPE

4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.2.4. OPPORTUNITY MATRIX

4.2.5. MARKET SEGMENTATION

4.2.5.1. GLOBAL CHROMATOGRAPHY REAGENTS MARKET

4.2.5.1.1. APPLICATIONS

4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.1.5. KEY CONCLUSIONS

4.2.5.2. GLOBAL ELECTROPHORESIS REAGENTS MARKET

4.2.5.2.1. APPLICATIONS

4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.2.5. KEY CONCLUSIONS

4.2.5.3. GLOBAL IMMUNOASSAY REAGANTS MARKET

4.2.5.3.1. APPLICATIONS

4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.3.5. KEY CONCLUSIONS

4.2.5.4. GLOBAL MICROARRAY REAGENT MARKET

4.2.5.4.1. APPLICATIONS

4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.4.5. KEY CONCLUSIONS

4.2.5.5. GLOBAL PROTEIN FRACTIONATION MARKET

4.2.5.5.1. APPLICATIONS

4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.5.5. KEY CONCLUSIONS

4.2.5.6. GLOBAL SPECTROSCOPY REAGENT MARKET

4.2.5.6.1. APPLICATIONS

4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.6.5. KEY CONCLUSIONS

4.2.5.7. GLOBAL X-RAYCRYSTALLOGRAPHY REAGENT MARKET

4.2.5.7.1. APPLICATIONS

4.2.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.2.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.2.5.7.4. TOP PLAYERS & KEY PRODUCTS

4.2.5.7.5. KEY CONCLUSIONS

4.3. GLOBAL PROTEOMICS MARKET BY SERVICES

4.3.1. MARKET DEFINITION AND SCOPE

4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.3.4. OPPORTUNITY MATRIX

4.3.5. MARKET SEGMENTATION

4.3.5.1. GLOBAL ANALYTICAL LABORATORY SERVICES MARKET

4.3.5.1.1. APPLICATIONS

4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.1.5. KEY CONCLUSIONS

4.3.5.2. GLOBAL PROTEIN IDENTIFICATION MARKET

4.3.5.2.1. APPLICATIONS

4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.2.5. KEY CONCLUSIONS

4.3.5.3. GLOBAL PROTEIN SEPARATION MARKET

4.3.5.3.1. APPLICATIONS

4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.3.5. KEY CONCLUSIONS

4.3.5.4. GLOBAL PROTEIN SEQUENCING MARKET

4.3.5.4.1. APPLICATIONS

4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.4.5. KEY CONCLUSIONS

4.3.5.5. GLOBAL DATA ANALYSIS & MAINTENANCE MARKET

4.3.5.5.1. APPLICATIONS

4.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.5.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.5.5. KEY CONCLUSIONS

4.3.5.6. GLOBAL BIOINFORMATICS DATABESES MARKET

4.3.5.6.1. APPLICATIONS

4.3.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.6.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.6.5. KEY CONCLUSIONS

4.3.5.7. GLOBAL BIOINFORMATICS TOOLS MARKET

4.3.5.7.1. APPLICATIONS

4.3.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.3.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.3.5.7.4. TOP PLAYERS & KEY PRODUCTS

4.3.5.7.5. KEY CONCLUSIONS

4.4. GLOBAL PROTEOMICS MARKET BY APPLICATION

4.4.1. MARKET DEFINITION AND SCOPE

4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.4. OPPORTUNITY MATRIX

4.4.5. MARKET SEGMENTATION

4.4.5.1. GLOBAL CLINICAL DIAGNOSIS MARKET

4.4.5.1.1. APPLICATIONS

4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS

4.4.5.1.5. KEY CONCLUSIONS

4.4.5.2. GLOBAL DRUG DISCOVERY MARKET

4.4.5.2.1. APPLICATIONS

4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS

4.4.5.2.5. KEY CONCLUSIONS

4.4.5.3. GLOBAL OTHERS MARKET

4.4.5.3.1. APPLICATIONS

4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS

4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS

4.4.5.3.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

5.1. KEY STRATEGIES

5.1.1. LIST OF MERGERS & ACQUISITION

5.1.2. LIST OF JOINT VENTURES

5.1.3. LIST OF PRODUCT LAUNCHES

5.1.4. LIST OF PARTNERSHIPS

5.2. TOP 10 COMPANY ANALYSIS

6. GLOBAL PROTEOMICS MARKET BY REGION

6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.3. OPPORTUNITY MATRIX

6.4. GEOGRAPHIC SEGMENTATION

6.4.1. NORTH AMERICA

6.4.1.1. INDUSTRY APPLICATION ANALYSIS

6.4.1.2. TOP COUNTRY ANALYSIS

6.4.1.2.1. U.S.

6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.1.3. KEY CONCLUSIONS

6.4.1.2.2. CANADA

6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.1.2.2.3. KEY CONCLUSIONS

6.4.2. EUROPE

6.4.2.1. INDUSTRY APPLICATION ANALYSIS

6.4.2.2. TOP COUNTRY ANALYSIS

6.4.2.2.1. UK

6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.1.3. KEY CONCLUSIONS

6.4.2.2.2. FRANCE

6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.2.3. KEY CONCLUSIONS

6.4.2.2.3. GERMANY

6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.3.3. KEY CONCLUSIONS

6.4.2.2.4. SPAIN

6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.4.3. KEY CONCLUSIONS

6.4.2.2.5. ITALY

6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.5.3. KEY CONCLUSIONS

6.4.2.2.6. REST OF EUROPE

6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ( $ MILLION)

6.4.2.2.6.2. TOP PLAYERS & KEY PRODUCTS

6.4.2.2.6.3. KEY CONCLUSIONS

6.4.3. ASIA PACIFIC

6.4.3.1. INDUSTRY APPLICATION ANALYSIS

6.4.3.2. TOP COUNTRY ANALYSIS

6.4.3.2.1. CHINA

6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.1.3. KEY CONCLUSIONS

6.4.3.2.2. INDIA

6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.2.3. KEY CONCLUSIONS

6.4.3.2.3. JAPAN

6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.3.3. KEY CONCLUSIONS

6.4.3.2.4. SOUTH KOREA

6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.4.3. KEY CONCLUSIONS

6.4.3.2.5. AUSTRALIA

6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.5.3. KEY CONCLUSIONS

6.4.3.2.6. REST OF ASIA PACIFIC

6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.3.2.6.2. TOP PLAYERS & KEY PRODUCTS

6.4.3.2.6.3. KEY CONCLUSIONS

6.4.4. ROW

6.4.4.1. INDUSTRY APPLICATION ANALYSIS

6.4.4.2. TOP COUNTRY ANALYSIS

6.4.4.2.1. LATIN AMERICA

6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.1.3. KEY CONCLUSIONS

6.4.4.2.2. MIDDLE EAST & AFRICA

6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)

6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS

6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

7.1. ABBOT LABORATORIES

7.1.1. OVERVIEW

7.1.2. PRODUCT PORTFOLIO

7.1.3. KEY INNOVATION/FOCUS SECTOR

7.1.4. STRATEGIC INITIATIVES

7.1.5. SCOT ANALYSIS

7.1.6. STRATEGIC ANALYSIS

7.2. BAUSCH & LOMB

7.2.1. OVERVIEW

7.2.2. PRODUCT PORTFOLIO

7.2.3. KEY INNOVATION/FOCUS SECTOR

7.2.4. STRATEGIC INITIATIVES

7.2.5. SCOT ANALYSIS

7.2.6. STRATEGIC ANALYSIS

7.3. COVIDIEN

7.3.1. OVERVIEW

7.3.2. PRODUCT PORTFOLIO

7.3.3. KEY INNOVATION/FOCUS SECTOR

7.3.4. STRATEGIC INITIATIVES

7.3.5. SCOT ANALYSIS

7.3.6. STRATEGIC ANALYSIS

7.4. DRAGER MEDICAL GMBH

7.4.1. OVERVIEW

7.4.2. PRODUCT PORTFOLIO

7.4.3. KEY INNOVATION/FOCUS SECTOR

7.4.4. STRATEGIC INITIATIVES

7.4.5. SCOT ANALYSIS

7.4.6. STRATEGIC ANALYSIS

7.5. FRESENIUS MEDICAL CARE AG & CO.KGAA

7.5.1. OVERVIEW

7.5.2. PRODUCT PORTFOLIO

7.5.3. KEY INNOVATION/FOCUS SECTOR

7.5.4. STRATEGIC INITIATIVES

7.5.5. SCOT ANALYSIS

7.5.6. STRATEGIC ANALYSIS

7.6. GENERAL ELECTRIC CO.

7.6.1. OVERVIEW

7.6.2. PRODUCT PORTFOLIO

7.6.3. KEY INNOVATION/FOCUS SECTOR

7.6.4. STRATEGIC INITIATIVES

7.6.5. SCOT ANALYSIS

7.6.6. STRATEGIC ANALYSIS

7.7. ITC

7.7.1. OVERVIEW

7.7.2. PRODUCT PORTFOLIO

7.7.3. KEY INNOVATION/FOCUS SECTOR

7.7.4. STRATEGIC INITIATIVES

7.7.5. SCOT ANALYSIS

7.7.6. STRATEGIC ANALYSIS

7.8. JOHNSON & JOHNSON INC.

7.8.1. OVERVIEW

7.8.2. PRODUCT PORTFOLIO

7.8.3. KEY INNOVATION/FOCUS SECTOR

7.8.4. STRATEGIC INITIATIVES

7.8.5. SCOT ANALYSIS

7.8.6. STRATEGIC ANALYSIS

7.9. MEDTRONIC INC.

7.9.1. OVERVIEW

7.9.2. PRODUCT PORTFOLIO

7.9.3. KEY INNOVATION/FOCUS SECTOR

7.9.4. STRATEGIC INITIATIVES

7.9.5. SCOT ANALYSIS

7.9.6. STRATEGIC ANALYSIS

7.10. MORTARA INSTRUMENTS INC.

7.10.1. OVERVIEW

7.10.2. PRODUCT PORTFOLIO

7.10.3. KEY INNOVATION/FOCUS SECTOR

7.10.4. STRATEGIC INITIATIVES

7.10.5. SCOT ANALYSIS

7.10.6. STRATEGIC ANALYSIS

7.11. NONIN MEDICAL

7.11.1. OVERVIEW

7.11.2. PRODUCT PORTFOLIO

7.11.3. KEY INNOVATION/FOCUS SECTOR

7.11.4. STRATEGIC INITIATIVES

7.11.5. SCOT ANALYSIS

7.11.6. STRATEGIC ANALYSIS

7.12. OMRON HEALTHCARE

7.12.1. OVERVIEW

7.12.2. PRODUCT PORTFOLIO

7.12.3. KEY INNOVATION/FOCUS SECTOR

7.12.4. STRATEGIC INITIATIVES

7.12.5. SCOT ANALYSIS

7.12.6. STRATEGIC ANALYSIS

7.13. PHILIPS HEALTHCARE

7.13.1. OVERVIEW

7.13.2. PRODUCT PORTFOLIO

7.13.3. KEY INNOVATION/FOCUS SECTOR

7.13.4. STRATEGIC INITIATIVES

7.13.5. SCOT ANALYSIS

7.13.6. STRATEGIC ANALYSIS

7.14. ROCHE DIAGNOSTICS LIMITED

7.14.1. OVERVIEW

7.14.2. PRODUCT PORTFOLIO

7.14.3. KEY INNOVATION/FOCUS SECTOR

7.14.4. STRATEGIC INITIATIVES

7.14.5. SCOT ANALYSIS

7.14.6. STRATEGIC ANALYSIS

7.15. SIEMENS AG

7.15.1. OVERVIEW

7.15.2. PRODUCT PORTFOLIO

7.15.3. KEY INNOVATION/FOCUS SECTOR

7.15.4. STRATEGIC INITIATIVES

7.15.5. SCOT ANALYSIS

7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

1. GLOBAL PROTEOMICS MARKET BY TECHNOLOGY2014-2023($ MILLION)

2. GLOBAL PROTEIN MICROARRAY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

3. GLOBAL BIOCHIPS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

4. GLOBAL PROTEIN CHIPS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

5. GLOBAL LAB-ON-CHIPS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

6. GLOBAL MICROARRAY INSTRUMENTS MARKET BY SECURITY SYSTEMS 2014-2023($ MILLION)

7. GLOBAL INTEGRATED SYSTEMS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

8. GLOBAL ARRAYERS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

9. GLOBAL MICROARRAY SCANERS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

10. GLOBAL SPECTROSCOPY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

11. GLOBAL CIRCULAR DICHROISM SPECTROSCOPY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

12. GLOBAL MASS SPECTROSCOPY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

13. GLOBAL NMS SPECTROSCOPY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

14. GLOBAL X-RAY CRYSTALLOGRAPHY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

15. GLOBAL CHROMATOGRAPHY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

16. GLOBAL AFFINITY CHROMATOGRAPHY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

17. GLOBAL HPLC SYSTEMS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

18. GLOBAL ION CHROMATOGRAPHY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

19. GLOBAL SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

20. GLOBAL ELECTROPHORESIS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

21. GLOBAL CAPILLARY ELECTROPHORESIS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

22. GLOBAL GEL ELECTROPHORESIS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

23. GLOBAL SURFACE PLASMON RESONANCE MARKET BY GEOGRAPHY 2014-2023($ MILLION)

24. GLOBAL PROTEIN FRACTIONATION SYSTEMS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

25. GLOBAL PROTEOMICS MARKET BY REAGENTS 2014-2023($ MILLION)

26. GLOBAL CHROMATOGRAPHY REAGENTS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

27. GLOBAL ELECTROPHORESIS REAGENTS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

28. GLOBAL IMMUNOASSAY REAGENTS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

29. GLOBAL MICROARRAY REAGENTS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

30. GLOBAL PROTEIN FRACTIONISATION REAGENTS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

31. GLOBAL SPECTROSCOPY REAGENTS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

32. GLOBAL PROTEOMICS MARKET BY SERVICES 2014-2023($ MILLION)

33. GLOBAL X-RAY CRYSTALLOGRAPHY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

34. GLOBAL ANALYTICAL LABORATORY SERVICES MARKET BY GEOGRAPHY 2014-2023($ MILLION)

35. GLOBAL PROTEIN IDENTIFICATION MARKET BY GEOGRAPHY 2014-2023($ MILLION)

36. GLOBAL PROTEIN SEPARATION MARKET BY GEOGRAPHY 2014-2023($ MILLION)

37. GLOBAL PROTEIN SEQUENCING MARKET BY GEOGRAPHY 2014-2023($ MILLION)

38. GLOBAL DATA ANALYSIS & MAINTENANCE MARKET BY GEOGRAPHY 2014-2023($ MILLION)

39. GLOBAL BIOINFORMATICS DATABASES MARKET BY GEOGRAPHY 2014-2023($ MILLION)

40. GLOBAL BIOINFORMATICS TOOLS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

41. GLOBAL PROTEOMICS MARKET BY APPLICATION 2014-2023($ MILLION)

42. GLOBAL CLINICAL DIAGNOSIS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

43. GLOBAL DRUG DISCOVERY MARKET BY GEOGRAPHY 2014-2023($ MILLION)

44. GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2023($ MILLION)

45. NORTH AMERICA PROTEOMICS MARKET2014-2023 ($MILLION)

46. EUROPE PROTEOMICS MARKET2014-2023 ($MILLION)

47. ASIA PACIFIC PROTEOMICS MARKET2014-2023 ($MILLION)

48. REST OF THE WORLD PROTEOMICS MARKET2014-2023 ($MILLION)

LIST OF FIGURES

1. GLOBAL PROTEOMICS MARKET BY PROTEIN MICROARRAY 2014-2023($ MILLION)

2. GLOBAL PROTEOMICS MARKET BY BIOCHIPS 2014-2023 ($ MILLION)

3. GLOBAL PROTEOMICS MARKET BY PROTEIN CHIPS 2014-2023 ($ MILLION)

4. GLOBAL PROTEOMICS MARKET BY LAB-ON-CHIPS 2014-2023 ($ MILLION)

5. GLOBAL PROTEOMICS MARKET BY MICROARRAY INSTRUMENTS 2014-2023($ MILLION)

6. GLOBAL PROTEOMICS MARKET BY INTEGRATED SYSTEMS 2014-2023 ($ MILLION)

7. GLOBAL PROTEOMICS MARKET BY ARRAYERS 2014-2023 ($ MILLION)

8. GLOBAL PROTEOMICS MARKET BY MICROARRAY SCANNERS 2014-2023 ($ MILLION)

9. GLOBAL PROTEOMICS MARKET BY SPECTROSCOPY 2014-2023($ MILLION)

10. GLOBAL PROTEOMICS MARKET BY CIRCULAR DICHROISM SPECTROSCOPY 2014-2023 ($ MILLION)

11. GLOBAL PROTEOMICS MARKET BY MASS SPECTROSCOPY 2014-2023 ($ MILLION)

12. GLOBAL PROTEOMICS MARKET BY NMR SPECTROSCOPY 2014-2023 ($ MILLION)

13. GLOBAL PROTEOMICS MARKET BY X-RAY CRYSTALLOGRAPHY 2014-2023($ MILLION)

14. GLOBAL PROTEOMICS MARKET BY CHROMATOGRAPHY 2014-2023 ($ MILLION)

15. GLOBAL PROTEOMICS MARKET BY AFFINITY CHROMATOGRAPHY 2014-2023 ($ MILLION)

16. GLOBAL PROTEOMICS MARKET BY HPLC SYSTEMS 2014-2023 ($ MILLION)

17. GLOBAL PROTEOMICS MARKET BY ION CHROMATOGRAPHY 2014-2023 ($ MILLION)

18. GLOBAL PROTEOMICS MARKET BY SUPERCRITICAL FLUID CHROMATOGRAPHY 2014-2023 ($ MILLION)

19. GLOBAL PROTEOMICS MARKET BY ELECTROPHORESIS 2014-2023 ($ MILLION)

20. GLOBAL PROTEOMICS MARKET BY CAPILLARY ELECTROPHORESIS 2014-2023 ($ MILLION)

21. GLOBAL PROTEOMICS MARKET BY GEL ELECTROPHORESIS 2014-2023 ($ MILLION)

22. GLOBAL PROTEOMICS MARKET BY SURFACE PLASMON RESONANCE 2014-2023 ($ MILLION)

23. GLOBAL PROTEOMICS MARKET BY PROTEIN FRACTIONATION SYSTEMS 2014-2023 ($ MILLION)

24. GLOBAL PROTEOMICS MARKET BY CHROMATOGRAPHY REAGENTS 2014-2023 ($ MILLION)

25. GLOBAL PROTEOMICS MARKET BY ELECTROPHORESIS REAGENTS 2014-2023 ($ MILLION)

26. GLOBAL PROTEOMICS MARKET BY IMMUNOASSAY REAGENTS 2014-2023 ($ MILLION)

27. GLOBAL PROTEOMICS MARKET BY MICROARRAY REAGENTS 2014-2023 ($ MILLION)

28. GLOBAL PROTEOMICS MARKET BY PROTEIN FRACTIONATION SYSTEMS 2014-2023 ($ MILLION)

29. GLOBAL PROTEOMICS MARKET BY SPECTROSCOPY REAGENT 2014-2023 ($ MILLION)

30. GLOBAL PROTEOMICS MARKET BY X-RAY CRYSTALLOGRAPHY 2014-2023 ($ MILLION)

31. GLOBAL PROTEOMICS MARKET BY ANALYTICAL LABORATORY SERVICES 2014-2023 ($ MILLION)

32. GLOBAL PROTEOMICS MARKET BY PROTEIN IDENTIFICATION 2014-2023 ($ MILLION)

33. GLOBAL PROTEOMICS MARKET BY PROTEIN SEPARATION 2014-2023 ($ MILLION)

34. GLOBAL PROTEOMICS MARKET BY PROTEIN SEQUENCING 2014-2023 ($ MILLION)

35. GLOBAL PROTEOMICS MARKET BY DATA ANALYSIS & MAINTENANCE 2014-2023 ($ MILLION)

36. GLOBAL PROTEOMICS MARKET BY BIOINFORMATICS DATABASES 2014-2023 ($ MILLION)

37. GLOBAL PROTEOMICS MARKET BY BIOINFORMATICS TOOLS 2014-2023 ($ MILLION)

38. GLOBAL PROTEOMICS MARKET BY CLINICAL DIAGNOSIS 2014-2023 ($ MILLION)

39. GLOBAL PROTEOMICS MARKET BY DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)

40. GLOBAL PROTEOMICS MARKET BY OTHERS 2014-2023 ($ MILLION)

41. UNITED STATES (U.S.) PROTEOMICS MARKET2014-2023 ($ MILLION)

42. CANADA PROTEOMICS MARKET 2014-2023 ($ MILLION)

43. UNITED KINGDOM (UK) PROTEOMICS MARKET 2014-2023 ($ MILLION)

44. GERMANY PROTEOMICS MARKET 2014-2023 ($ MILLION)

45. SPAIN PROTEOMICS MARKET 2014-2023 ($ MILLION)

46. ITALY PROTEOMICS MARKET 2014-2023 ($ MILLION)

47. FRANCE PROTEOMICS MARKET 2014-2023 ($ MILLION)

48. ROE PROTEOMICS MARKET 2014-2023 ($ MILLION)

49. INDIA PROTEOMICS MARKET 2014-2023 ($ MILLION)

50. CHINA PROTEOMICS MARKET 2014-2023 ($ MILLION)

51. JAPAN PROTEOMICS MARKET 2014-2023 ($ MILLION)

52. KOREA PROTEOMICS MARKET 2014-2023 ($ MILLION)

53. ROWAPAC PROTEOMICS MARKET 2014-2023 ($ MILLION)

54. LATIN AMERICA PROTEOMICS MARKET 2014-2023 ($ MILLION)

55. MENA PROTEOMICS MARKET 2014-2023 ($ MILLION)

Login

Forgot Password

Thank you for your request!

Thank you for downloading..!

Global Proteomics Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

FAQ

Request for Sample

UPCOMING REPORTS

NAVIGATION LINK

OUR SERVICES

CONNECT WITH US